Congress Faces Internal Turmoil in Bahadurgarh as Rajesh Joon Resigns Over Ticket Denial The Congress party is experiencing a fresh wave of dissent in Bahadurgarh ahead of the 2024 Haryana Assembly elections, as Rajesh Joon has resigned from the party in protest against being denied a ticket. Joon, who previously served as the party's Bahadurgarh president, expressed his disappointment over the decision, which he believes undermines the contributions of dedicated party workers. This incident marks a continuation of the internal strife within the Congress, reminiscent of previous rebellions in the region. Joon's resignation has raised concerns about the party's unity and its ability to secure votes in the upcoming elections, particularly as it seeks to regain ground against rival parties. In his resignation statement, Joon emphasized the need for the party leadership to consider the aspirations of grassroots members and to foster a more inclusive decision-making process. T...
Revolutionary Eye Drops, PresVu, Offer Quick Relief from Reading Glasses
Entod Pharmaceuticals has made a significant breakthrough in eye care with the approval of PresVu eye drops by the Drugs Controller General of India (DCGI). This innovative treatment is designed specifically for individuals suffering from presbyopia, a common age-related condition that affects the ability to focus on nearby objects, typically emerging in those over 40 years old.Globally, an estimated 1.09 billion to 1.80 billion people are affected by presbyopia, which can severely impact daily activities and overall quality of life. Many individuals realize they have this condition when they find themselves needing to hold reading materials at arm's length to see clearly.PresVu eye drops stand out as India's first non-invasive solution for presbyopia, providing relief from the need for reading glasses within just 15 minutes of application. The drops utilize advanced dynamic buffer technology, which quickly adapts to the pH of tears, ensuring prolonged effectiveness while also lubricating the eyes.Nikhil K. Masurkar, CEO of Entod Pharmaceuticals, emphasized that the development of PresVu was the result of extensive research and development efforts. He described the product as more than just an eye drop; it represents a transformative solution for millions seeking improved vision without the hassle of glasses.Dr. Aditya Sethi highlighted the significance of PresVu, noting that it offers a practical alternative to traditional treatments such as reading glasses, contact lenses, and surgical options. The eye drops not only enhance near vision but also contribute to a better quality of life, allowing individuals to engage in everyday tasks with greater ease.Overall, the approval of PresVu marks a promising advancement in ophthalmology, providing a much-needed non-invasive option for those struggling with presbyopia.
Comments
Post a Comment